Mycoplasma infection with M. Arginini results in NF-κB constitutive activation and inhibition of apoptosis in cells expressing toll-like receptors TLR2/6

Molecular Genetics, Microbiology and Virology

Volumn 23, Issue 4, 2008, Pages 163-167

  Shcheblyakov, D V ^a   Logunov, D Yu ^a   Zubkova, O V ^a   Shmarov, M M ^a   Rakovskaya, I V ^a   Naroditskii, B S ^a   Gintsburg, A L ^a   Gudkov, A V ^b  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPLASMA; MYCOPLASMA ARGININI;

EID: 70349586771     PISSN: 08914168     EISSN: 1934841X     Source Type: Journal    
DOI: 10.3103/S0891416808040022     Document Type: Article

References (20)

1. Prozorovskii, S.V., Rakovskaya, I.V., and Vul'fovich, Yu.V., Meditsinskaya mikoplazmologiya (Medical Mycoplasmology), Moscow, 1995.
2. B.B. Aggarwal 2004 Cancer Cell 6 203 208 15380510 10.1016/j.ccr.2004.09. 003 1:CAS:528:DC%2BD2cXot1Kis78%3D
3. G.M. Barton R. Medzhitov 2003 Science 300 1524 1525 12791976 10.1126/science.1085536 1:CAS:528:DC%2BD3sXktlKru7w%3D
4. H.H. Backus H.M. Pinedo D. Wouters, et al. 2000 Oncol. Res. 12 5 231 239 11417748 1:CAS:528:DC%2BD38XltlOkug%3D%3D
5. R.J. Carmody Y.H. Chen 2007 Cell. Mol. Immunol. 4 1 31 41 17349209 1:CAS:528:DC%2BD2sXkvVWqsr0%3D
6. K. Farhat S. Riekenberg H. Heine, et al. 2008 J. Leukoc. Biol. 83 3 692 701 18056480 10.1189/jlb.0807586 1:CAS:528:DC%2BD1cXjtVaqtLY%3D
7. M. Gerlic J. Horowitz S. Horowitz 2004 Cell Death Differ. 11 11 1204 1212 15286682 10.1038/sj.cdd.4401482 1:CAS:528:DC%2BD2cXosVSksb4%3D
8. M.S. Hayden S. Ghosh 2004 Genes Dev. 18 2195 2224 15371334 10.1101/gad.1228704 1:CAS:528:DC%2BD2cXnslCntbY%3D
9. Johnson, S.W., Stevenson, J.P., and O'Dwyer, P.J., Cancer Principles and Practice of Oncology, 2001, p. 376.
10. A. Kaufmann P.F. Muhlradt D. Gemsa H. Sprenger 1999 Infect. Immun. 67 12 6303 6308 10569741 1:CAS:528:DyaK1MXns1yltbo%3D
11. S.A. Lakhani A. Masud K. Kuida, et al. 2006 Science 311 847 851 16469926 10.1126/science.1115035 1:CAS:528:DC%2BD28XhtFylsb4%3D
12. A. Liihrmann K. Grote M. Stephan, et al. 2007 Immunol. Lett. 108 2 167 173 10.1016/j.imlet.2006.12.008
13. H.H. Mu J. Humphreys F.V. Chan B.C. Cole 2006 Cell. Microbiol. 8 3 414 426 16469054 10.1111/j.1462-5822.2005.00630.x 1:CAS:528:DC%2BD28XivFKgtbc%3D
14. P.F. Muhlradt H. Quentmeier E. Schmitt 1991 Infect. Immun. 59 3962 3968 1937754 1:STN:280:By2D2c%2Fgs1A%3D
15. T. Okamoto T. Sanda K. Asamitsu 2007 Curr. Pharm. Des. 13 5 447 462 17348842 10.2174/138161207780162944 1:CAS:528:DC%2BD2sXjvVylt78%3D
16. S. Razin D. Yogev Y. Naot 1998 Microbiol. Mol. Biol. Rev. 62 1094 1156 9841667 1:CAS:528:DyaK1MXhs1Onsg%3D%3D
17. S. Rottem 2003 Physiol. Rev. 83 2 417 432 12663864 1:CAS:528: DC%2BD3sXjtVagtr0%3D
18. T. Shimizu Y. Kida K. Kuwano 2004 Immunology 113 1 121 129 15312143 10.1111/j.1365-2567.2004.01937.x 1:CAS:528:DC%2BD2cXnsVKmuro%3D
19. T. Shimizu Y. Kida K. Kuwano 2005 J. Immunol. 175 7 4641 4646 16177110 1:CAS:528:DC%2BD2MXhtVWltbjL
20. K. Takeda O. Takeuchi S. Akira 2002 J. Endotoxin Res. 8 6 459 463 12697090 1:CAS:528:DC%2BD3sXptVOqtQ%3D%3D